Tau Protein Phosphorylation
Tau Protein Phosphorylation - Related Videos
12:55
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
0 Views •
Cited by 11 •
2017
This manuscript describes standard protocols for measuring tau hyperphosphorylation, measuring tau binding to microtubules, and localization of intracellular tau following drug treatments. These protocols can be used repetitively for screening drugs or other compounds that target tau hyperphosphorylation or microtubule binding.
01:25
Detection of Phosphorylated Tau Proteins in Mouse Brain Samples Using Western Blot Analysis
0 Views •
2025
Homogenize the tissue to release proteins into the buffer. The protease inhibitors block protease activity, preventing protein degradation.
04:22
Phosphatase Assay in CRC Cells: A Method to Examine the Phosphorylation Status of Tau Protein in Colorectal Cancer Cells
0 Views •
2023
This video describes a protocol for assessing the phosphorylation status of tau protein by a phosphatase assay in colorectal cancer cells. Phosphatase enzyme acts on the phosphate groups present on the tau protein, increasing the mobility of tau protein on SDS PAGE gel compared to the untreated tau protein samples.
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
0 Views •
Cited by 21 •
2015
Unmodified and hyperphosphorylated tau proteins were used in two in vitro aggregation assays to reveal the hyperphosphorylation-dependent fast aggregation kinetics. These assays pave the way for future screens for compounds that can modulate the propensity of hyperphosphorylated tau to form fibrils that underlie the progression of Alzheimer’s disease.
12:47
Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
0 Views •
Cited by 25 •
2016
We describe here a method to identify multiple phosphorylations of an intrinsically disordered protein by Nuclear Magnetic Resonance Spectroscopy (NMR), using Tau protein as a case study. Recombinant Tau is isotopically enriched and modified in vitro by a kinase prior to data acquisition and analysis.
FAQs
Tau phosphorylation reflects a reversible balance between two enzyme activities. Protein kinases add phosphate groups by transferring them from ATP to selected tau residues, whereas phosphatases remove those groups. The relative activity of these enzymes can therefore alter tau’s biochemical behavior, including its interaction with microtubules, cellular location, and activity within neuronal cells.
The phosphate groups are attached to specific serine, threonine, or tyrosine residues, so phosphorylation does not produce one uniform molecular state. Which residues are modified can influence tau regulation and its association with microtubules. This residue-specific control helps explain how changes in phosphorylation can affect neuronal cytoskeletal organization rather than simply changing tau activity in a nonspecific way.
Excessive or abnormal modification can weaken tau’s interactions with microtubules, reducing its contribution to cytoskeletal stability. Tau may then become associated with paired helical filaments, which can contribute to neurofibrillary tangle formation. The biochemical consequence is therefore linked to both loss of normal microtubule support and accumulation of altered tau structures in affected neurons.
A study can compare kinase-driven phosphate addition with phosphatase-mediated removal, then evaluate consequences for tau–microtubule interactions, cellular location, and activity. Investigators may also examine whether altered phosphorylation is associated with paired helical filaments or neurofibrillary tangles. These measurements connect molecular regulation to structural and functional changes in the neuronal cytoskeleton.
Its relevance lies in the connection between altered tau regulation and neuronal cytoskeletal disruption. Abnormal phosphorylation can reduce microtubule interactions and promote filament and tangle formation, processes associated with Alzheimer’s disease and related tauopathies. Studying these links helps researchers investigate how biochemical changes in tau may contribute to disease-associated cellular damage.
Research on tau phosphorylation supports several directions: testing kinase inhibitors, examining phosphatase regulation, developing diagnostic biomarkers, and exploring potential therapeutic strategies. The process also provides a biochemical framework for connecting enzyme activity with tau aggregation and cytoskeletal disruption. These applications help translate molecular observations into approaches for detecting or addressing tau-related disease mechanisms.